Fréderic Emschermann

754 total citations
14 papers, 522 citations indexed

About

Fréderic Emschermann is a scholar working on Cardiology and Cardiovascular Medicine, Immunology and Hematology. According to data from OpenAlex, Fréderic Emschermann has authored 14 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 7 papers in Immunology and 4 papers in Hematology. Recurrent topics in Fréderic Emschermann's work include Atherosclerosis and Cardiovascular Diseases (5 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers) and Platelet Disorders and Treatments (3 papers). Fréderic Emschermann is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (5 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers) and Platelet Disorders and Treatments (3 papers). Fréderic Emschermann collaborates with scholars based in Germany, United States and Switzerland. Fréderic Emschermann's co-authors include Harald F. Langer, Hanns-Joachim Rziha, Michael R. Knittler, Manuela Sauter, Meinrad Gawaz, Frank Edlich, Henry Nording, Joachim Lauterwasser, Stephen W. G. Tait and Franziska Todt and has published in prestigious journals such as Circulation, The EMBO Journal and Blood.

In The Last Decade

Fréderic Emschermann

14 papers receiving 515 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fréderic Emschermann Germany 10 225 174 81 73 71 14 522
Vernon Seow Australia 7 127 0.6× 173 1.0× 35 0.4× 24 0.3× 71 1.0× 7 426
Robert Buckland United Kingdom 12 248 1.1× 48 0.3× 172 2.1× 53 0.7× 58 0.8× 19 545
Pichugin Av Russia 12 168 0.7× 148 0.9× 17 0.2× 39 0.5× 45 0.6× 43 448
Michel Pontet France 14 235 1.0× 156 0.9× 27 0.3× 40 0.5× 34 0.5× 26 529
Sara Francesca Santagostino United States 12 182 0.8× 83 0.5× 28 0.3× 27 0.4× 22 0.3× 25 422
Gabriele Zybarth United States 9 533 2.4× 344 2.0× 55 0.7× 27 0.4× 31 0.4× 10 780
Daniela Pintérová Czechia 11 166 0.7× 84 0.5× 24 0.3× 82 1.1× 31 0.4× 18 503
Mohammad Bagher Hashemi‐Soteh Iran 13 102 0.5× 43 0.2× 31 0.4× 48 0.7× 38 0.5× 48 414
Fahad Al-Zoghaibi Saudi Arabia 12 274 1.2× 194 1.1× 28 0.3× 19 0.3× 18 0.3× 16 557
Katja Conrath Belgium 15 243 1.1× 84 0.5× 80 1.0× 21 0.3× 46 0.6× 23 718

Countries citing papers authored by Fréderic Emschermann

Since Specialization
Citations

This map shows the geographic impact of Fréderic Emschermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fréderic Emschermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fréderic Emschermann more than expected).

Fields of papers citing papers by Fréderic Emschermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fréderic Emschermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fréderic Emschermann. The network helps show where Fréderic Emschermann may publish in the future.

Co-authorship network of co-authors of Fréderic Emschermann

This figure shows the co-authorship network connecting the top 25 collaborators of Fréderic Emschermann. A scholar is included among the top collaborators of Fréderic Emschermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fréderic Emschermann. Fréderic Emschermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Zdanytė, Monika, Peter Martus, Fréderic Emschermann, et al.. (2022). Risk assessment in COVID‐19: Prognostic importance of cardiovascular parameters. Clinical Cardiology. 45(9). 943–951. 2 indexed citations
2.
Sauter, Manuela, et al.. (2022). Protocol to isolate and analyze mouse bone marrow derived dendritic cells (BMDC). STAR Protocols. 3(3). 101664–101664. 41 indexed citations
3.
Nording, Henry, Manuela Sauter, Sven Geisler, et al.. (2022). Activated Platelets Upregulate β2 Integrin Mac-1 (CD11b/CD18) on Dendritic Cells, Which Mediates Heterotypic Cell–Cell Interaction. The Journal of Immunology. 208(7). 1729–1741. 10 indexed citations
4.
Emschermann, Fréderic, Peter Martus, Oliver Borst, et al.. (2022). Platelet SR-PSOX/CXCL16–CXCR6 Axis Influences Thrombotic Propensity and Prognosis in Coronary Artery Disease. International Journal of Molecular Sciences. 23(19). 11066–11066. 6 indexed citations
5.
Rohlfing, Anne‐Katrin, Fréderic Emschermann, Tilman E. Schäffer, et al.. (2021). Characterization of GPVI- or GPVI-CD39-Coated Nanoparticles and Their Impact on In Vitro Thrombus Formation. International Journal of Molecular Sciences. 23(1). 11–11. 5 indexed citations
6.
Rohlfing, Anne‐Katrin, Tatsiana Castor, Fréderic Emschermann, et al.. (2021). Platelet-Derived PCSK9 Is Associated with LDL Metabolism and Modulates Atherothrombotic Mechanisms in Coronary Artery Disease. International Journal of Molecular Sciences. 22(20). 11179–11179. 38 indexed citations
7.
Fu, Xiaoqing, Fréderic Emschermann, Johannes Rheinlaender, et al.. (2021). Platelet ACKR3/CXCR7 favors antiplatelet lipids over an atherothrombotic lipidome and regulates thromboinflammation. Blood. 139(11). 1722–1742. 28 indexed citations
8.
Sauter, Manuela, Edimara S. Reis, Fréderic Emschermann, et al.. (2018). Functional Relevance of the Anaphylatoxin Receptor C3aR for Platelet Function and Arterial Thrombus Formation Marks an Intersection Point Between Innate Immunity and Thrombosis. Circulation. 138(16). 1720–1735. 86 indexed citations
9.
Emschermann, Fréderic, Christine S. Zuern, Johannes Patzelt, et al.. (2016). Resistance to renal denervation therapy — Identification of underlying mechanisms by analysis of differential DNA methylation. IJC Heart & Vasculature. 11. 80–86. 2 indexed citations
10.
Nording, Henry, Johannes Patzelt, Manuela Sauter, et al.. (2016). Platelet bound oxLDL shows an inverse correlation with plasma anaphylatoxin C5a in patients with coronary artery disease. Platelets. 27(6). 593–597. 14 indexed citations
11.
Heinzmann, David, Anna‐Maria Müller, Saskia N. I. von Ungern‐Sternberg, et al.. (2015). The Novel Extracellular Cyclophilin A (CyPA) - Inhibitor MM284 Reduces Myocardial Inflammation and Remodeling in a Mouse Model of Troponin I -Induced Myocarditis. PLoS ONE. 10(4). e0124606–e0124606. 34 indexed citations
12.
Todt, Franziska, Frank Reichenbach, Fréderic Emschermann, et al.. (2014). Differential retrotranslocation of mitochondrial Bax and Bak. The EMBO Journal. 34(1). 67–80. 137 indexed citations
13.
Emschermann, Fréderic, et al.. (2012). Orf virus interferes with MHC class I surface expression by targeting vesicular transport and Golgi. BMC Veterinary Research. 8(1). 114–114. 77 indexed citations
14.
Stellos, Konstantinos, Manuela Sauter, Juliane Grimm, et al.. (2012). Binding of Oxidized Low-Density Lipoprotein on Circulating Platelets Is increased in Patients With Acute Coronary Syndromes and Induces Platelet Adhesion to Vascular Wall In Vivo—Brief Report. Arteriosclerosis Thrombosis and Vascular Biology. 32(8). 2017–2020. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026